Company page
Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. (ticker: SLNO) is a public company based in the United States with a market capitalization of approximately $2.76 billion. The company focuses on developing innovative therapies for rare diseases. Soleno aims to address unmet medical needs through its research and development efforts.
- Ticker
- SLNO:NASDAQ
- Asset type
- Stock
- Market cap
- $2.76B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD